Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Biogen in the Drug Discovery & Development Pharma 50

Biogen

Rank: 28

2021 Rank: 21

Cambridge, Massachusetts, United States
www.biogen.com

2021 Revenues ($USD) : $10,981,700,000
2021 R&D spend : $2,501,200,000
2021 Number of Employees : 9,610
Fiscal Year End : 12/31/2021
Leader : CEO Michel Vounatsos

Focusing on developing therapies for neurological and neurodegenerative diseases, Biogen made headlines in 2021 when it won FDA approval for the first Alzheimer’s therapy, Aduhelm (aducanumab), in almost 20 years. That approval, however, proved to be controversial. As a result, Aduhelm brought in only $3 million in 2021. Other headwinds included waning sales of the multiple sclerosis drug Ocrevus (ocrelizumab), which fell 18% in 2021, while the spinal muscular atrophy therapy Spinraza (nusinersen) had a 7% revenue decrease. Overall, the company’s 2021 revenue dipped 18% over the prior year at actual currency. In 2022, the company began adopting cost-cutting measures to shore up its bottom line. —BB

Biogen headquarters

[Biogen headquarters. Image courtesy of Biogen.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50